GAMMA Investing’s Cidara Therapeutics CDTX Stock Holding History

GAMMA Investing’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-101	Closed	-$22.3K	–	4131
2025 Q4	$22.3K	Buy	101 +89	+742%	+$14.4K	﹤0.01%	2545
2025 Q3	$1.15K	Buy	+12	New	+$766	﹤0.01%	3585

GAMMA Investing's CDTX Position: Q1 2026 in Review

GAMMA Investing sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 101 shares — an estimated $22.3K sold.

GAMMA Investing first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $22.3K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

GAMMA Investing reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
GAMMA Investing sold 101 Cidara Therapeutics shares in Q1 2026, an estimated $22.3K.
GAMMA Investing first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
GAMMA Investing's Cidara Therapeutics position peaked at $22.3K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on GAMMA Investing's 13F filing for Q1 2026, filed 6 Apr 2026.